DENTSPLY SIRONA Stock Down Slightly Despite Positive Market Performance

April 21, 2023

Trending News 🌧️

Despite an overall positive Stock Market performance on Tuesday, shares of Dentsply Sirona ($NASDAQ:XRAY) Inc. (Nasdaq: XRAY) declined by 0.87%, closing at $40.56. Dentsply Sirona is a leading manufacturer and distributor of dental and oral healthcare products and technologies. The company offers a variety of products, including consumables and equipment, endodontic systems, orthodontic systems, dental implants, dental laboratory products, imaging systems, and infection control products. Despite the slight decline in stock price yesterday, Dentsply Sirona continues to be a successful and growing company due to its diverse product offerings and strong financials.

Price History

On Wednesday, DENTSPLY SIRONA, a dental technology and equipment supplier, saw its stock open at $40.4 and close at $40.6. This 0.1% increase in the stock’s closing price from the previous day was relatively minor in comparison to the previously positive market performance of the company. However, this small rebound did not lead to any significant growth for the company’s stock. DENTSPLY SIRONA’s stock ended the day slightly lower than it started. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Dentsply Sirona. More…

    Total Revenues Net Income Net Margin
    3.92k -950 5.9%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Dentsply Sirona. More…

    Operations Investing Financing
    517 -138 -329
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Dentsply Sirona. More…

    Total Assets Total Liabilities Book Value Per Share
    7.64k 3.83k 17.7
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Dentsply Sirona are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    -0.9% -6.2% -25.4%
    FCF Margin ROE ROA
    9.4% -16.8% -8.1%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    GoodWhale has analyzed DENTSPLY SIRONA‘s financials and has rated it as a high risk investment. Our Risk Rating takes into account financial and business aspects to help users determine the potential risk of investing in a particular company. On closer inspection, GoodWhale has flagged two risk warnings in DENTSPLY SIRONA’s income sheet and balance sheet. To learn more about these risks, we invite you to become a registered user on our platform and check it out. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    In the competitive world of dental equipment manufacturers, Dentsply Sirona Inc. has held its own against some tough competitors. Edwards Lifesciences Corp, Escalon Medical Corp, and Medistim ASA are all companies that produce dental equipment and supplies that compete with Dentsply Sirona Inc.

    – Edwards Lifesciences Corp ($NYSE:EW)

    Edwards Lifesciences Corp is a medical technology company that specializes in products and technologies for the treatment of cardiovascular diseases. The company’s market capitalization is $45.45 billion as of 2022, and its return on equity is 18.9%. Edwards Lifesciences is headquartered in Irvine, California, and has operations in more than 75 countries worldwide.

    – Escalon Medical Corp ($OTCPK:ESMC)

    Escalon Medical Corp is a medical device company that manufactures and markets products for the ophthalmology, optometry, and veterinary markets worldwide. It has a market cap of 800.11k as of 2022 and a return on equity of 1.57%. The company’s products include ophthalmic surgical instruments, intraocular lenses, contact lenses, and disposables.

    – Medistim ASA ($BER:MD1)

    Medistim ASA is a Norwegian medical device company that develops, manufactures, and markets products for use in cardiac and vascular surgery. The company has a market capitalization of 455.95 million as of 2022 and a return on equity of 24.86%. Medistim’s products are used in a variety of procedures, including coronary artery bypass graft surgery, valve replacement surgery, and endovascular surgery. The company’s products are sold in over 50 countries worldwide.

    Summary

    Dentsply Sirona Inc. stock price slipped 0.87% on Tuesday in an overall mixed market. With the company’s fundamentals in focus, investors may want to pay closer attention to the stock in the coming months.

    Recent Posts

    Leave a Comment